Citations

Institution: Mayo Clinic Clear

Showing 10 of 108119 citations.

A retrospective study of gender differences in depressive symptoms and risk of relapse in patients with alcohol dependence
Karpyak, Victor M. , Schneekloth, Terry D. , Hall‐Flavin, Daniel K., Loukianova, Larissa L., Geske, Jennifer R. , Mrazek, David A. , Frye, Mark A. , Abulseoud, Osama A. , Biernacka, Joanna M. , Karpyak, Victor , Geske, Jennifer

The American Journal on Addictions | May 30, 2013 | Volume: 22 | Issue: 5 | Pages: 437-442

10.1111/j.1521-0391.2013.12021.x | PMID 23952888 Get It

Background and ObjectivesThe aim of this study was to investigate potential gender differences in situations associated with heavy alcohol drinking.MethodsData from 395 alcohol dependent patients participating in the Mayo Clinic Intensive Addiction Program were evaluated. Each participant completed the inventory of drug taking situations (IDTS), Penn alcohol craving scale (PACS), patient health questionnaire (PHQ‐9), and/or Beck depression inventory (BDI). Gender differences in IDTS scores representing three domains (negative, positive, and temptation) of situations associated with heavy alcohol use were examined.ResultsWomen with alcohol dependence report a higher frequency of heavy drinking in unpleasant emotional (IDTS negative scores mean ± SD women vs. men: 52.3 ± 22.1 vs. 43.8 ± 21.8; p = .0006), and as a result of temptation (IDTS temptation scores mean ± SD women vs. men: 40.4 ± 23.0 vs. 35.3 ± 20.8; p = .035). Upon admission, women also scored significantly higher on depressive symptoms as measured by the BDI (23.4 ± 11.4 vs. 18.2 ± 9.8, p < .001). After controlling for depressive symptom severity as a covariate, the IDTS gender differences were no longer significant.Conclusion and Scientific SignificanceOur results suggest that unpleasant or temptation based emotional situations are a vulnerability risk factor for heavy drinking particularly in females. This risk appears to be at least partially driven by depressive symptom burden. Future research is needed to further investigate this finding. (Am J Addict 2013;22:437–442)
Diagnostic Yield and Safety of Endoscopic Ultrasound Guided Fine Needle Aspiration of Central Mediastinal Lung Masses
Vázquez-Sequeiros, Enrique , Levy, Michael J. , Domselaar, Manuel Van , González-Panizo, Fernando, Foruny, José Ramón , Boixeda-Miquel, Daniel, Juzgado-Lucas, Diego, Lucas, Diego Juzgado, Albillos, Agustı́n

Diagnostic and Therapeutic Endoscopy | May 30, 2013 | Volume: 2013 | Issue: No issue available | Pages: 1-6

10.1155/2013/150492 | PMID 23818747 Get It

Background and Aims . EUS-FNA is an accurate and safe technique to biopsy mediastinal lymph nodes. However, there are few data pertaining to the role of EUS-FNA to biopsy central lung masses. The aim of the study was to assess the diagnostic yield and safety of EUS-FNA of indeterminate central mediastinal lung masses. Methods . Design: Retrospective review of a prospectively maintained database; noncomparative. Setting: Tertiary referral center. From 10/2004 to 12/2010, all patients with a lung mass located within proximity to the esophagus were referred for EUS-FNA. Main Outcome Measurement: EUS-FNA diagnostic accuracy and safety. Results . 73 consecutive patients were included. EUS allowed detection in 62 (85%) patients with lack of visualization prohibiting FNA in 11 patients. Among sampled lesions, one patient (1/62 = 1.6%) had a benign lung mass (hamartoma), while the remaining 61 patients (61/62 = 98.4%) had a malignant mass (primary lung cancer: 55/61 = 90%; lung metastasis: 6/61 = 10%). The sensitivity, specificity, and accuracy of EUS-FNA were 96.7%, 100%, and 96.7%, respectively. The sensitivity was 80.8% when considering nonvisualized masses. One patient developed a pneumothorax (1/62 = 1.6%). Conclusions . EUS-FNA appears to be an accurate and safe technique for tissue diagnosis of central mediastinal lung masses.
Neurocritical Care
Wijdicks, Eelco F. M. , Rabinstein, Alejandro A.

No container title available | May 30, 2013 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1093/med/9780199843626.001.0001 Get It

Abstract This resource provides the clinician with specific focus and insight on interventions in acute neurologic disorders. Neurocritical care in daily practice pertains to managing deteriorating patients, treatment of complications but also end-of-life care assisting families with difficult decisions.
Systemic mastocytosis in adults: 2013 update on diagnosis, risk stratification, and management
Pardanani, Animesh

American Journal of Hematology | May 30, 2013 | Volume: 88 | Issue: 7 | Pages: 612-624

10.1002/ajh.23459 | PMID 23720340 Get It

Disease overview:Systemic mastocytosis (SM) results from a clonal proliferation of abnormal mast cells (MC) in one or more extracutaneous organs.Diagnosis:The major criterion is presence of multifocal clusters of morphologically abnormal MC in the bone marrow. Minor diagnostic criteria include elevated serum tryptase level, abnormal MC expression of CD25 and/or CD2, and presence of KITD816V.Risk stratification:The 2008 World Health Organization (WHO) classification of SM has been shown to be prognostically relevant. Classification of SM patients into indolent (SM), aggressive SM (ASM), SM associated with a clonal non‐MC lineage disease (SM‐AHNMD) and mast cell leukemia (MCL) subgroups is a useful first step in establishing prognosis.Management:SM treatment is generally palliative. ISM patients have a normal life expectancy and receive symptom‐directed therapy; infrequently, cytoreductive therapy may be indicated for refractory symptoms. ASM patients have disease‐related organ dysfunction; interferon‐α (±corticosteroids) can control dermatological, hematological, gastrointestinal, skeletal, and mediator‐release symptoms, but is hampered by poor tolerability. Similarly, cladribine has broad therapeutic activity, with particular utility when rapid MC debulking is indicated; the main toxicity is myelosuppression. Imatinib has a therapeutic role in the presence of an imatinib‐sensitive KIT mutation or in KITD816‐unmutated patients. Treatment of SM‐AHNMD is governed primarily by the non‐MC neoplasm; hydroxyurea has modest utility in this setting.Investigational drugs:Dasatinib's in vitro anti‐ KITD816V activity has not translated into significant therapeutic activity in most SM patients. In contrast, recently updated data confirms Midostaurin's significant anti‐MC activity in patients with advanced SM. Am. J. Hematol. 88:612–624, 2013. © 2013 Wiley Periodicals, Inc.
Simultaneous Kidney Transplantation and Bilateral Native Nephrectomy for Polycystic Kidney Disease
Tyson, Mark D. , Wisenbaugh, Eric S., Andrews, Paul E. , Castle, Erik P., Humphreys, Mitchell R. , Schwartz, Joseph E. , Knechtle, Stuart J.

Journal of Urology | May 30, 2013 | Volume: 190 | Issue: 6 | Pages: 2170-2174

10.1016/j.juro.2013.05.057 | PMID 23727414 Get It

Nurses' attitudes, abilities and educational preference related to using family pedigrees in clinical practice
Pestka, Elizabeth L., Shah, Lisa , Junglen, Laura M., Delgado, Adriana, Meiers, Sonja J.

International Journal of Nursing Practice | May 30, 2013 | Volume: No volume available | Issue: No issue available | Pages: n/a-n/a

10.1111/ijn.12091 | PMID 24093741 Get It

Retromer maintains basolateral distribution of the type II TGF-β receptor via the recycling endosome
Yin, Xueqian , Wilkes, Mark C. , Leof, Edward B. , Murphy, Stephen J. , Ji, Yan

Molecular Biology of the Cell | May 30, 2013 | Volume: 24 | Issue: 14 | Pages: 2285-2298

10.1091/mbc.e13-02-0093 | PMID 23720763 Get It

Transforming growth factor β (TGF-β) is critical for the development and maintenance of epithelial structures. Because receptor localization and trafficking affect the cellular and organismal response to TGF-β, the present study was designed to address how such homeostatic control is regulated. To that end, we identify a new role for the mammalian retromer complex in maintaining basolateral plasma membrane expression of the type II TGF-β receptor (TβRII). Retromer and TβRII associate in the presence or absence of TGF-β ligand. After retromer knockdown, although TβRII internalization and trafficking to a Rab5-positive compartment occur as in wild-type cells, receptor recycling is inhibited. This results in TβRII mislocalization from the basolateral to both the basolateral and apical plasma membranes independent of Golgi transit and the Rab11-positive apical recycling endosome. The data support a model in which, after initial basolateral TβRII delivery, steady-state polarized TβRII expression is maintained by retromer/TβRII binding and delivery to the common recycling endosome.
Neurodegeneration, Königsberg, and the New York City subway
Jones, David T. , Seeley, William W.

Neurology | May 30, 2013 | Volume: 81 | Issue: 2 | Pages: 104-106

10.1212/wnl.0b013e31829a3553 | PMID 23719146 Get It

Genetic Variants That Confer Resistance to Malaria Are Associated with Red Blood Cell Traits in African-Americans: An Electronic Medical Record-based Genome-Wide Association Study
Ding, Keyue , Manolio, Teri A. , Crawford, Dana C. , Rasmussen‐Torvik, Laura J. , Ritchie, Marylyn D. , Denny, Joshua C. , Masys, Daniel R., Jouni, Hayan, Pachecho, Jennifer A, Roden, Dan M. , Chisholm, Rex L. , Andrade, Mariza de , Kho, Abel , Roden, Dan M. , Kullo, Iftikhar J. , Denny, Joshua C , Rasmussen-Torvik, Laura J

G3 Genes|Genomes|Genetics | May 29, 2013 | Volume: 3 | Issue: 7 | Pages: 1061-1068

10.1534/g3.113.006452 | PMID 23696099 Get It

Abstract To identify novel genetic loci influencing interindividual variation in red blood cell (RBC) traits in African-Americans, we conducted a genome-wide association study (GWAS) in 2315 individuals, divided into discovery (n = 1904) and replication (n = 411) cohorts. The traits included hemoglobin concentration (HGB), hematocrit (HCT), RBC count, mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), and mean corpuscular hemoglobin concentration (MCHC). Patients were participants in the electronic MEdical Records and GEnomics (eMERGE) network and underwent genotyping of ~1.2 million single-nucleotide polymorphisms on the Illumina Human1M-Duo array. Association analyses were performed adjusting for age, sex, site, and population stratification. Three loci previously associated with resistance to malaria—HBB (11p15.4), HBA1/HBA2 (16p13.3), and G6PD (Xq28)—were associated (P ≤ 1 × 10−6) with RBC traits in the discovery cohort. The loci replicated in the replication cohort (P ≤ 0.02), and were significant at a genome-wide significance level (P &lt; 5 × 10−8) in the combined cohort. The proportions of variance in RBC traits explained by significant variants at these loci were as follows: rs7120391 (near HBB) 1.3% of MCHC, rs9924561 (near HBA1/A2) 5.5% of MCV, 6.9% of MCH and 2.9% of MCHC, and rs1050828 (in G6PD) 2.4% of RBC count, 2.9% of MCV, and 1.4% of MCH, respectively. We were not able to replicate loci identified by a previous GWAS of RBC traits in a European ancestry cohort of similar sample size, suggesting that the genetic architecture of RBC traits differs by race. In conclusion, genetic variants that confer resistance to malaria are associated with RBC traits in African-Americans.
MR characterization of hepatic storage iron in transfusional iron overload
Tang, Haiying, Jensen, Jens H. , Sammet, Christina L., Sheth, Sujit , Swaminathan, Srirama V., Hultman, Kristi, Wu, EX , Brown, Truman R. , Brittenham, Gary M. , Kim, Daniel , Kim, Daniel , Kim, Daniel

Journal of Magnetic Resonance Imaging | May 29, 2013 | Volume: 39 | Issue: 2 | Pages: 307-316

10.1002/jmri.24171 | PMID 23720394 Get It

PurposeTo quantify the two principal forms of hepatic storage iron, diffuse, soluble iron (primarily ferritin), and aggregated, insoluble iron (primarily hemosiderin) using a new MRI method in patients with transfusional iron overload.Materials and MethodsSix healthy volunteers and 20 patients with transfusion‐dependent thalassemia syndromes and iron overload were examined. Ferritin‐ and hemosiderin‐like iron were determined based on the measurement of two distinct relaxation parameters: the “reduced” transverse relaxation rate, RR2, and the “aggregation index,” A, using three sets of Carr‐Purcell‐Meiboom‐Gill (CPMG) datasets with different interecho spacings. Agarose phantoms, simulating the relaxation and susceptibility properties of tissue with different concentrations of dispersed (ferritin‐like) and aggregated (hemosiderin‐like) iron, were used for validation.ResultsBoth phantom and in vivo human data confirmed that transverse relaxation components associated with the dispersed and aggregated iron could be separated using the two‐parameter (RR2, A) method. The MRI‐determined total hepatic storage iron was highly correlated (r = 0.95) with measurements derived from biopsy or biosusceptometry. As total hepatic storage iron increased, the proportion stored as aggregated iron became greater.ConclusionThis method provides a new means for noninvasive MRI determination of the partition of hepatic storage iron between ferritin and hemosiderin in iron overload disorders. J. Magn. Reson. Imaging 2014;39:307–316. © 2013 Wiley Periodicals, Inc.